Xiao Li-Hao, Li Hai-Bo, Huang Yu-Xin, Qin Da-Peng, Zhang Chen-Feng, Wang Zhen-Zhong, Yu Yang
State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process,Kanion Pharmaceutical Co.,Ltd. Lianyungang 222001,China.
Institute of Traditional Chinese Medicine and Natural Products,College of Pharmacy,Jinan University Guangzhou 510632,China.
Zhongguo Zhong Yao Za Zhi. 2021 Mar;46(5):1160-1167. doi: 10.19540/j.cnki.cjcmm.20210107.601.
Chemical constituents were isolated and purified from the water extract of Artemisia annua by column chromatography of HP-20 macroporous resin, silica gel, ODS, Sephadex LH-20, HW-40, and semi-preparative RP-HPLC. Their structures were elucidated by physicochemical properties and spectral analyses. As a result, Fifteen compounds were isolated and identified as vitexnegheteroin M(1), sibricose A5(2), securoside A(3), citrusin D(4), annphenone(5), E-melilotoside(6), esculetin(7), scopoletin-7-O-β-D-glucoside(8), eleutheroside B_1(9), chrysosplenol D(10), patuletin-3-O-β-D-glucopyranoside(11), quercetin-7-O-β-D-glucoside(12), rutin(13), apigenin 6,8-di-C-β-D-glucopyranoside(14), isoschaftoside(15), among them, compounds 1-4 were identified from Artemisia for the first time. Additionally, the isolates were evaluated for their inhibitory effects on the production of PGE_2 in LPS-simulated RAW264.7 macrophages. The results showed that compounds 1, 2, 8, and 10-15 could reduce PGE_2 levels, to a certain extent.
采用HP - 20大孔树脂、硅胶、ODS、Sephadex LH - 20、HW - 40柱色谱及半制备RP - HPLC从黄花蒿水提取物中分离纯化化学成分。通过理化性质和光谱分析对其结构进行鉴定。结果,分离鉴定出15个化合物,分别为牡荆异苷M(1)、西伯利亚糖A5(2)、安全苷A(3)、柑橘苷D(4)、青蒿酮(5)、E - 草木犀苷(6)、七叶内酯(7)、东莨菪素 - 7 - O - β - D - 葡萄糖苷(8)、刺五加苷B_1(9)、金腰醇D(10)、紫铆亭 - 3 - O - β - D - 吡喃葡萄糖苷(11)、槲皮素 - 7 - O - β - D - 葡萄糖苷(12)、芦丁(13)、芹菜素6,8 - 二 - C - β - D - 吡喃葡萄糖苷(14)、异荭草苷(15),其中化合物1 - 4为首次从黄花蒿中分离得到。此外,对分离得到的化合物进行了LPS诱导的RAW264.7巨噬细胞中PGE_2生成抑制作用的评价。结果表明,化合物1、2、8及10 - 15在一定程度上可降低PGE_2水平。